Kwok-Yung Yuen to Treatment Outcome
This is a "connection" page, showing publications Kwok-Yung Yuen has written about Treatment Outcome.
Connection Strength
0.124
-
Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant. Emerg Infect Dis. 2018 12; 24(12):2241-2250.
Score: 0.029
-
The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy. Antiviral Res. 2018 12; 160:38-47.
Score: 0.028
-
Treatment With Lopinavir/Ritonavir or Interferon-ß1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J Infect Dis. 2015 Dec 15; 212(12):1904-13.
Score: 0.023
-
Antiviral therapy for respiratory tract infections. Respirology. 2008 Nov; 13(7):950-71.
Score: 0.014
-
Medical treatment of viral pneumonia including SARS in immunocompetent adult. J Infect. 2004 Nov; 49(4):262-73.
Score: 0.011
-
Vedolizumab-mediated integrin a4ß7 blockade does not control HIV-1SF162 rebound after combination antiretroviral therapy interruption in humanized mice. AIDS. 2019 03 15; 33(4):F1-F12.
Score: 0.007
-
Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models. J Infect Dis. 2018 07 02; 218(3):365-377.
Score: 0.007
-
Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax. 2004 May; 59(5):414-20.
Score: 0.003
-
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004 Mar; 59(3):252-6.
Score: 0.003